| abstract |
COMBINED THERAPY FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS. The present invention relates to a method for treating a patient diagnosed with, or at risk of developing an immunoinflammatory disorder, by administering a non-steroidal immunophilin-dependent immunosuppressant (NsIDI) and an intensifier (for example, antifungal agent, antigen agent, anti-infectious agent, antiprotozoal agent, antiviral agent, humectant, sunscreen, vitamin D compound, microtubulin inhibitor, or zinc salt) or similar or matabolic to the patient. The invention also features a pharmaceutical composition containing an NsIDI and a Group A enhancer or analog or metabolite thereof for the treatment or prevention of an immunoinflammatory disorder. |